# Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19

> **NCT04861298** · NA · COMPLETED · sponsor: **King Edward Medical University** · enrollment: 100 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** standard of care for COVID-19 as per the hospital guidelines
- **DIETARY_SUPPLEMENT:** Quercetin Phytosome (QP)

## Key facts

- **NCT ID:** NCT04861298
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2021-08-29
- **Final completion:** 2021-08-29
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04861298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04861298, "Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04861298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*